Tower Research Capital (TRC)’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $362K | Buy |
5,597
+2,504
| +81% | +$177K | 0.01% | 1165 |
|
|
2025
Q4 | $208K | Sell |
3,093
-1,523
| -33% | -$102K | 0.01% | 1410 |
|
|
2025
Q3 | $339K | Sell |
4,616
-32,652
| -88% | -$2.17M | 0.01% | 1109 |
|
|
2025
Q2 | $1.94M | Buy |
37,268
+31,418
| +537% | +$1.79M | 0.05% | 316 |
|
|
2025
Q1 | $373K | Sell |
5,850
-14,276
| -71% | -$829K | 0.01% | 1014 |
|
|
2024
Q4 | $962K | Buy |
20,126
+16,002
| +388% | +$821K | 0.02% | 651 |
|
|
2024
Q3 | $236K | Sell |
4,124
-20,242
| -83% | -$1.16M | 0.01% | 1465 |
|
|
2024
Q2 | $1.28M | Buy |
24,366
+20,320
| +502% | +$891K | 0.02% | 625 |
|
|
2024
Q1 | $165K | Sell |
4,046
-18,695
| -82% | -$701K | ﹤0.01% | 1536 |
|
|
2023
Q4 | $841K | Buy |
22,741
+8,974
| +65% | +$338K | 0.01% | 983 |
|
|
2023
Q3 | $526K | Buy |
13,767
+5,028
| +58% | +$206K | 0.02% | 843 |
|
|
2023
Q2 | $315K | Buy |
8,739
+2,597
| +42% | +$88.6K | 0.01% | 1264 |
|
|
2023
Q1 | $235K | Buy |
6,142
+1,239
| +25% | +$58.1K | 0.01% | 1277 |
|
|
2022
Q4 | $279K | Sell |
4,903
-7,926
| -62% | -$406K | 0.01% | 1073 |
|
|
2022
Q3 | $507K | Sell |
12,829
-17,660
| -58% | -$781K | 0.01% | 1127 |
|
|
2022
Q2 | $1.34M | Buy |
30,489
+22,145
| +265% | +$958K | 0.03% | 537 |
|
|
2022
Q1 | $332K | Sell |
8,344
-6,370
| -43% | -$227K | ﹤0.01% | 1413 |
|
|
2021
Q4 | $592K | Sell |
14,714
-451
| -3% | -$16.8K | 0.01% | 998 |
|
|
2021
Q3 | $617K | Sell |
15,165
-14,558
| -49% | -$609K | 0.02% | 842 |
|
|
2021
Q2 | $1.35M | Sell |
29,723
-6,882
| -19% | -$305K | 0.04% | 467 |
|
|
2021
Q1 | $1.53M | Buy |
36,605
+25,614
| +233% | +$1.17M | 0.03% | 579 |
|
|
2020
Q4 | $469K | Buy |
10,991
+7,374
| +204% | +$265K | 0.01% | 1031 |
|
|
2020
Q3 | $95K | Sell |
3,617
-16,875
| -82% | -$470K | ﹤0.01% | 3183 |
|
|
2020
Q2 | $550K | Buy |
+20,492
| New | +$462K | 0.02% | 936 |
|
|
2020
Q1 | – | Sell |
-22,347
| Closed | -$396K | – | 3386 |
|
|
2019
Q4 | $396K | Buy |
22,347
+22,280
| +33,254% | +$386K | 0.03% | 350 |
|
|
2019
Q3 | $1K | Sell |
67
-133
| -67% | -$2.19K | ﹤0.01% | 3868 |
|
|
2019
Q2 | $3K | Sell |
200
-1,618
| -89% | -$26.1K | ﹤0.01% | 3141 |
|
|
2019
Q1 | $29K | Buy |
1,818
+1,428
| +366% | +$23.1K | ﹤0.01% | 2068 |
|
|
2018
Q4 | $6K | Buy |
+390
| New | +$6.22K | ﹤0.01% | 2796 |
|
|
2018
Q3 | – | Sell |
-1,369
| Closed | -$23K | – | 3960 |
|
|
2018
Q2 | $23K | Buy |
+1,369
| New | +$25.9K | ﹤0.01% | 2353 |
|
|
2017
Q4 | – | Sell |
-13,989
| Closed | -$243K | – | 3710 |
|
|
2017
Q3 | $243K | Buy |
+13,989
| New | +$189K | 0.02% | 627 |
|
|
2017
Q1 | – | Sell |
-8,247
| Closed | -$81K | – | 3395 |
|
|
2016
Q4 | $81K | Buy |
8,247
+5,341
| +184% | +$58.5K | 0.01% | 1087 |
|
|
2016
Q3 | $35K | Buy |
2,906
+2,131
| +275% | +$21.8K | ﹤0.01% | 1323 |
|
|
2016
Q2 | $7K | Sell |
775
-733
| -49% | -$7.23K | ﹤0.01% | 3138 |
|
|
2016
Q1 | $14K | Buy |
+1,508
| New | +$14.2K | ﹤0.01% | 1624 |
|
|
2015
Q4 | – | Sell |
-9,779
| Closed | -$131K | – | 4689 |
|
|
2015
Q3 | $131K | Buy |
+9,779
| New | +$196K | 0.01% | 436 |
|
|
2015
Q2 | – | Sell |
-806
| Closed | -$12K | – | 4632 |
|
|
2015
Q1 | $12K | Buy |
+806
| New | +$11.6K | ﹤0.01% | 2636 |
|
|
2014
Q3 | – | Sell |
-70
| Closed | -$667 | – | 4583 |
|
|
2014
Q2 | $1K | Sell |
70
-30,066
| -100% | -$255K | ﹤0.01% | 3669 |
|
|
2014
Q1 | $383K | Buy |
30,136
+29,678
| +6,480% | +$441K | 0.05% | 259 |
|
|
2013
Q4 | $7K | Sell |
458
-3,475
| -88% | -$44.7K | ﹤0.01% | 3291 |
|
|
2013
Q3 | $43K | Buy |
3,933
+3,921
| +32,675% | +$32.7K | ﹤0.01% | 2047 |
|
|
2013
Q2 | $0 | Buy |
+12
| New | +$76 | ﹤0.01% | 3942 |
|
Other funds holding HALO
VCM
VPM
Tower Research Capital (TRC)'s HALO Position: Q1 2026 in Review
Tower Research Capital (TRC) increased its Halozyme (HALO) stake by 81% in Q1 2026, buying an estimated $177K and bringing the position to 5,597 shares worth $362K. The position accounts for 0.01% of the portfolio, ranked #1165.
Tower Research Capital (TRC) first reported a position in HALO in Q2 2013 and has held it in 42 quarters since. The position peaked at $1.94M in Q2 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Tower Research Capital (TRC) held 5,597 shares of Halozyme worth $362K as of Q1 2026.
- Tower Research Capital (TRC) bought 2,504 Halozyme shares in Q1 2026, an estimated $177K.
- Halozyme made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1165 holding.
- Tower Research Capital (TRC) first reported a position in Halozyme in Q2 2013 and has held it in 42 quarters since.
- Tower Research Capital (TRC)'s Halozyme position peaked at $1.94M in Q2 2025.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.